CVS Health — Aug 5, 2026 release

lion • Raising full-year 2026 guidance: ◦ GAAP diluted EPS guidance range to $6.84 to $7.04 from $6.24 to $6.44 ◦ Adjusted EPS guidance range to $7.90 to $8.10 from $7.30 to $7.50 ◦ Cash flow from operations guidance to at least $11.5 billion from at least $9.5 billion WOONSOCKET, RHODE ISLAND, August 5, 2026 - CVS Health Corporation (NYSE: CVS) today announced operating results for the three months ended June 30, 2026. “Our CVS Health colleagues build trust every day in communities across our country by making healthcare easier for millions of customers, patients and members. As our businesses work together to deliver a technology-powered care engagement experience, we continue to deliver strong performance. We uniquely enable what our customers want the most: simple, connected and convenient access to affordable, quality healthcare, where, when, and how they want it.”                                                                                                            - David Joyner, CVS Health Chairman and CEO Three Months Ended June 30, Year Ending December 31, In billions, except per share amounts 2026 2025 2026 Projected Total revenues $ 106.1  $ 98.9  At least $414.0 Diluted earnings per share $ 2.31  $ 0.80  $6.84-$7.04 Adjusted EPS (2) $ 2.58  $ 1.81  $7.90-$8.10 Second quarter GAAP diluted EPS of $2.31 increased from $0.80 in the prior year. Adjusted EPS of $2.58 increased from $1.81 in the prior year, p